Cetera Investment Advisers’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Sell
12,755
-351
-3% -$4.27K ﹤0.01% 4594
2026
Q1
$183K Sell
13,106
-1,510
-10% -$21.2K ﹤0.01% 4309
2025
Q4
$210K Sell
14,616
-2,193
-13% -$33K ﹤0.01% 4199
2025
Q3
$268K Sell
16,809
-3,565
-17% -$58.7K ﹤0.01% 3927
2025
Q2
$361K Sell
20,374
-120
-0.6% -$2.34K ﹤0.01% 3238
2025
Q1
$427K Sell
20,494
-343
-2% -$6.5K ﹤0.01% 2970
2024
Q4
$385K Sell
20,837
-250
-1% -$4.81K ﹤0.01% 2901
2024
Q3
$413K Sell
21,087
-6,371
-23% -$127K ﹤0.01% 2812
2024
Q2
$539K Sell
27,458
-2,692
-9% -$51.1K ﹤0.01% 2536
2024
Q1
$543K Sell
30,150
-115,794
-79% -$2.1M ﹤0.01% 2536
2023
Q4
$2.47M Buy
145,944
+9,756
+7% +$194K 0.02% 703
2023
Q3
$2.7M Buy
136,188
+16,585
+14% +$314K 0.02% 628
2023
Q2
$2.24M Sell
119,603
-40,223
-25% -$811K 0.02% 718
2023
Q1
$3.26M Buy
159,826
+80,712
+102% +$1.62M 0.03% 539
2022
Q4
$1.68M Buy
+79,114
New +$1.64M 0.02% 772

Other funds holding BTAL

Cetera Investment Advisers's BTAL Position: Q2 2026 in Review

Cetera Investment Advisers reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 2.7% in Q2 2026, selling an estimated $4.27K and leaving 12,755 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #4594.

Cetera Investment Advisers first reported a position in BTAL in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.26M in Q1 2023. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Cetera Investment Advisers held 12,755 shares of AGF US Market Neutral Anti-Beta Fund worth $142K as of Q2 2026.
  • Cetera Investment Advisers sold 351 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $4.27K.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4594 holding.
  • Cetera Investment Advisers first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and has held it in 15 quarters since.
  • Cetera Investment Advisers's AGF US Market Neutral Anti-Beta Fund position peaked at $3.26M in Q1 2023.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.